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Sudden unexpected cardiac death is the most devastating 
feature of the natural history of hype~rophic cardiomyopa- 
thy and in many patients is the first clinical manifestation of 
the disease (1-7). Although left ventricular hypertrophy 
appears to be an important determinant of many functional 
features of hypertrophic cardiomyopathy, the reialion be- 
tween the magnitude of hypertrophy and the occurrence of 
sudden cardiac death has not been defined. To investigate the 
relation between these two co ponents of the disease, we 
assessed the extent of left ventricular hypertrophy (by two- 
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dimensional echocardiography) in a relatively large group of 
asymptomatic or mildly symptomatic patients with hyper- 
trophic cardiomyopathy who s~bseq~e~t~y died s~d~e~~y or 
experienced cardiac arrest, and compared these morphologic 
findings with those obtained in a control group of surviving 
patients with this disease. 
iae arrest. Twenty~~ifle 
had been 
institute 
between January 1980 and March 1987 and who subse- 
quently died suddenly or were successfully resuscitated after 
cardiac arrest with documentation of ventricular ~b~l~ation 
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form the present study group. Sudden death was defined as 
instantaneous collapse with subsequent death within min- 
utes or documented ventricular fibrillation. 
In each patient, the diagnosis of hypertrophic cardiomy- 
opathy had been established by the echocardiographic dem- 
onstration of a nondilated and hypertrophied left ventricle 
in the absence of another cardiac or systemic disease that 
could produce left ventricular hypertrophy of the magnitude 
observed (8) Patients ranged in age from 11 to 62 years 
(mean 30); 17 (60%) were male. For convenience, we will 
refer to the study patients who either died suddenly or 
survived cardiac arrest as patients experiencing sudden 
cardiac death. 
Each of the 29 patients met the following selection 
criteria: 1) no or only mild symptoms (New York Weart 
Association functional class I or II) before their catastrophic 
and unexpected event, and 2) a two-dimensional echocardio- 
gram of sufficient technical quality to permit reliable assess- 
ment of the extent and distribution of left ventricular hyper- 
trophy. The time interval between the two-dimensional 
echocardiogram and sudden death or cardiac arrest was cl 
year (range 1 to 11 months, mean 3) in 23 patients. In the 
remaining six patients, the two-dimensional echocardiogram 
was obtained 1.9 to 4.6 years (mean 2.9) before sudden 
death. Patients who had undergone operation (ventricular 
septal myotomy-myectomy) for relief of subaortic obstruc- 
tion and subsequently died suddenly were not included in the 
study. 
By virtue of selection criteria, the 29 study patients had 
no or only mild symptoms before their sudden death; 15 
patients (52%) were asymptomatic and 14 (48%) had mild 
symptoms that did not represent significant functional limi- 
tation (that is, functional class II). The most common 
symptoms were exertionai dyspnea, fatigue, chest pain and 
presyncope; six patients had experienced syncope. Although 
patients with severe symptoms of cardiac failure can also die 
suddetJy, we confined our study to those patients who had 
not hmi marked cardiac symptoms before their catastrophic 
event. We believe that data obtained in this fashion will 
ultimately be more pertinent to our understanding of the 
determinants of unexpected sudden death in hypertrophic 
cardiomyopathy. 
An Advanced Technolog oratory Mark 500 mechan- 
ical sector scanner with a 3 transducer and a Hewlett- 
Packard 7702OA or a Vari -3000 or V-3400) phased- 
array sector scanner with 2.25 MHz transducers were used 
to perform the two-dimensional echocardiographic studies. 
Images were recorded on 1 in. (2.54 cm) reel to reel 
videotape. Two-dimensional echocardiographic images were 
obtained in the parasternal long- and short-axis views and 
apical two and four chamber views, using standard trans- 
ducer positions (11). 
Lefr ventricular outflow tract obstruction und:* basal 
conditions was assessed at cardiac catheterization in 20 
patients, and estimated from the M-mode echocardiogram 
(on the basis of the magnitude aud duration of systolic 
anterior motion of the mitral valve) in the remaining 9 
patients (9,lO). In each of the former 20 patients, cardiac 
catheterization was performed within 17 months (mean 3) of 
the two-dimensional echocardiogram used to assess the 
extent of left ventricular hypertrophy. 
Assessment of magnitude of hypert y. The extent and 
distribution of left ventricular hypertrophy were assessed at 
end-diastole, utilizing criteria previously described (12-U). 
Briefly, the magnitude of left ventricular hypertrophy was 
assessed primarily from parasternal short-axis planes; hsw- 
ever, parasternal long-axis and apical views were also used 
to integrate the observations made from the short-axis 
views. In particular, the long-axis view was used to verify 
the measurements of anterior septal and posterior free wall 
thickness obtained from the short-axis views; the apical 
views were used primarily to exclude the presence of apical 
hypertrophy in those patients in whom, on the basis of the 
parastemal views, hypertrophy was considered to be mild 
and localized to the basal portions of the ventricle. 
Significant narrowing of the extramural coronary arteries 
was excluded by coronary atteriography or by gross visual 
In the parastemal short-axis plane, the left ventricle was 
inspection at necropsy in 11 patients. In the other 18 study 
divided into four segments that identified the anterior 
patients, the presence of coronary artery disease was con- 
and posterior ventricular septum and the lateral and poste- 
rior left ventricular free walls (Fig. 1). Wall thickness was 
sidered unlikely because of their youthful age (range 9 to 37 
years; mean 21). 
Control patients. Morphologic findings in the study pa- 
tients with sudden cardiac death were compared with those 
in a control group of surviving patients with hypertrophic 
cardiomyopathy. The control group represented a series of 
95 patients evaluated at the National Heart, Lung, and Blood 
Institute between February 1982 and rch 1986 who had 
two-dimensional echocardiograms 
quality to permit reliable asse 
distribution of left ventricular h 
were selected so that they represen 
and symptomatic status to that of the patients who died 
suddenly. 
At the time of their echocardiographic examination, the 
control patients ranged in age from 9 to 61 years (mean 31); 
71(75%) were male. Forty-five patients were asymptomatic, 
and 50 others were mildly symptomatic (functional class II). 
Left ventricular outflow tract obstruction under basal con- 
ditions was assessed at cardiac catheterization in 24 patients 
and estimated from the M-mode echocardiogram in the other 
71. The only cardioactive medication administered to the 
control patients was a beta-adrenergic blocking agent or 
verapamil. 
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. Patterns of left ventricular hy 
patients with ~ypertro~~i 
short-axis plane during di 
diogram from a 21 year an (Case 12) shows 
marked ~y~e~ro~hy of the anterior ventricular septum 
(AMT. WI, which measures up to 32 mm 
ening also involves the posterior septu 
and contiguous portion of the anterior 
WI. , Echocardiogram from a 14 year old 
6) shows relatively mild and localized wall t 
primarily involving the anterior portion of the ventricu- 
lar septum (I5 mm). LAT. FW = lateral free wall. 
at the levels of both t 
papillary muscles in each of the four v 
The segment of the wall that showed the 
ness was considered to represent the maximal left ven- 
tricular wall thickness (13-16). In 
the extent of left ventricular hype 
by adding the maximal wall t 
mitral valve or papillary muscle level) in each of the four 
ventricular segments (14). This index was considered repre- 
sentative of the overall magnitude of left ventricular hyper- 
trophy. urements of maximal left ventricular wall thick- 
ness an thickness index have previously been shown to 
have satisfactory reproducibility (14.16). These measure- 
ments provide an adequate estimate of the extent of left 
ventricular hypertrophy and reliably separate, in quantita- 
tive terms, patients with marked and diffuse hypertrophy 
from those with mild and localized hy~e~ro~by ( 12- 15). Left 
ventricular end-diastolic cavity dimension was assessed 
from the M-mode echocardiogram, as previously described 
Data were expressed as mean values 
f SD. Differences between condinuous variables were de- 
termined using the unpaired Student’s t test. Differences 
between proportions were determined using the chi-square 
test or the Fisher exact test. as appropriate. 
es 
Ec~~a~d~ograp~ic dings. The 29 study patients with 
sudden cardiac death and the 95 control patients were 
compared with regard to the magnitude of left ventricular 
ypertrophy. aximal left ve~tr~c~~ar wall th 
sured from the two-dimensional echoca~diogra 
icantly greater in patients with sudden death 
than in the control gr 
The left ventricular 
overall extent of left ventricular 
greater in patients with sudden de 
control patients (62 
end-diastolic cavity dimension wa 
(42 a: 6 and 44 + 6 mm, respectively, p > 0.05). 
Furthermore, patients at the extremes of the morphologic 
spectrum of the disease showed a strikj~gly different preva- 
lence within the two study groups. Particularly marked and 
diffuse left ventricular hypertrophy, with maximal wall 
thickness 230 mm or wall thickness 225 mm in two or more 
of the four segments into which the left ventricle bad been 
divided, was eight times mon in patients with 
sudden death (I I [38%] of the control patients (5 
[5%] of 95, p < 0.001) (Fig. 3). Mild and localized hypertro- 
phy, with maximal wall thickness ~17 mm involving only 
one ventricular segment, showed a similar prevalence in the 
patients with sudden death (4 [I 291 and in control 
patients (23 [24%] of 95, p > 0.05). ver, only one of the 
four patients with sudden death an localized hypertro- 
phy was an adult (Case 27). The other three 
cent children (Cases 5. 6 and 7) whose hyp 
have been classified as more substantial if cot 
surface area. In 27 (93%) of the 29 patients with sudden 
death, the anterior ventricular septum was the thickest 
portion of the left ventricle. No patient had hypertrophy 
confined to the most distal apical portion of the left ventricle 
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Figure 2. Comparison of maximal eft ventricular (LV) wall thick- 
ness in patients with sudden cardiac death and in surviving control 
patients. 8 = mean value. 
below papipsry muscle level (that is, “apical hypertrophic 
cardiomyopathy”) (l&19). 
ClWeal fhraimgs. Clinical, morphologic and functional 
findings in the 29 study patients with sudden death are 
reported in Table 1. Age at the time of the patient’s cata- 
strophic event ranged from 11 to 62 years (mean 30); eight 
patients were ~18 years of age and four were >50 years. 
Seventeen (59%) of the 29 study patients were male. Sudden 
death occurred in 22 patients during sedentary activity and in 
Figure 3. Prevalence of severe and mild left ventricular hypertrophy 
(LVH) in patients with sudden cardiac death and in surviving 
control patients. 
Sudden Death 
calllmls 
the other 7 during moderate to 
running, jogging or lifting weight. 
severe exertion such as 
Twenty-one of the 29 patients had been taking ~~rd~oac- 
give medication in the period just before their catastrophic 
event, including beta-blockers (12 patients), verapamil (3 
patients), both verapamil and propranolol(2 patients), ami- 
odarone (1 patient), disopyramide and propranolol (1 pa- 
tient), nifedipine and propranolol(1 patient) and digitalis and 
diuretic (1 patient). 
In 2 of the 29 patients, hypertrophic cardiomyopathy was 
associated with another cardiovascular abnormality. One 
patient (Case 4) had an anatomically redundant floppy mitral 
valve with systolic prolapse but without significant mitral 
regurgitation, and the other (Case 14) had mild systemic 
hypertension. Subaortic obstruction under basal conditions 
(pressure gradient 230 mm Hg) was present in 10 (34%) of 
the 29 study patients with sudden cardiac death. This prev- 
alence of subaortic obstruction was not significantly different 
from that in the control group (16 [17%] of 95, p > 0.05). 
Gender distribution also did not differ in the patients with 
sudden death (17 [59%] of the 29 study patients were male 
patients compared with 71 [75%1 of the 95 control patients, 
p > 0.05). 
Previous studies have shown that the presence of marked 
and diffuse left ventricular hypertrophy is an unfavorable 
feature in patients with hypertrophic cardiomyopathy. Pa- 
tients with extensive hypertrophy have a higher prevalence 
of obstruction to left ventricular outtlow (6,20,21) and non- 
sustained ventricular tachycardia on ambulatory electrocar- 
diography (6,22), a finding associated with increased risk for 
sudden death (23,24). The present study extends these 
observations and demonstrates a relation between the extent 
of left ventricular hypertrophy and the occurrence of sudden 
death or cardiac arrest in this disease. 
ilation between extent of hypertropiny and occurrence of 
sudden death. Both maximal left ventricular wall thickness 
and wail thickness index (a measure of the overall magnitude 
of left ventricular hypertrophy) were significantly greater in 
our group of patients who died suddenly or experienced 
cardiac arrest than in a representative control group of 
surviving patients with hypertrophic cardiomyopathy of 
similar age and functional status. Furthermore, analysis of 
extent of left ventricular hypertrophy in individual patients 
showed that particularly marked and diffuse hypertrophy, 
with maximal wall thickness 230 mm or wall thickness ~25 
mm in two or more left ventricular segments, was eight times 
more common in patients with sudden cardiac death than in 
the control patients. At the other extreme of the morphologic 
spectrum of the disease, mild and localized left ventricular 
hypertrophy, with maximal wall thickness 117 mm involv- 
ing only one ventricular segment, was uncommon in patients 
JACC Vol. 1.5. Fdo. 7 
June 1990~1521-6 
RrrO AND N 
D SUDDEN 
I325 
H 
* Clinical, 
Survived cardiac Arrest 
ied Suddenly or 
LVOT Gradient Maximal LV Wall 
Age” LV Walall Thickness 
Case (yr)/ Functional Circumstances Medications at Time of LVEDP Thickness 
No. Gender Class SD or CA at Time of SD SD Basal Provokabl 
I 
2 
3 
4 
5 
6 
1 
8 
9 
10 
I1 
I2 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
I I/M 
l31M 
13/M 
14/M 
14/M 
14/M 
15/M 
17/F 
21/M 
21/F 
21/F 
21/F 
22/M 
24lF 
251M 
25/M 
26lF 
32/M 
33/F 
35/F 
35/M 
37lF 
41/M 
46/M 
47/M 
51/F 
60/F 
61/F 
62/M 
CA 
SD 
SD 
SD 
SD 
SD 
CA 
SD 
CA 
CA 
SD 
CA 
SD 
CA 
SD 
SD 
CA 
CA 
CA 
SD 
CA 
SD 
CA 
SD 
CA 
CA 
CA 
CA 
CA 
Sedentary 
Sedentary 
Sedentary 
Sedentary 
Running 
Sedentary 
Jogging 
Running 
Sedentary 
Sedentary 
Sleeping 
Sedentary 
Sedentary 
Sedentary 
Sedentary 
Walking 
Sedentary 
Jogging 
After jogging 
Walking 
Sedentary 
Sedentary 
Sedentary 
Sedentary 
Sedentary 
Sedentary 
Running upstairs 
Sedentary 
Lifting weights 
None 
Propranolol 
Pro~ranolol 
None 
Verapamil 
PropraooloUaifed~piae 
None 
None 
Verapami~pro~ranolol 
Atenolol 
Di~italis/diurelics 
Atenolol 
Atenolol 
Propranolol 
None 
Verapamil 
None 
None 
Propranolol 
Propranolol 
Amiodarone 
Propranolol 
Propranolol 
None 
PropranoloVdisopyramide 
Propranolol 
VerapamiUpropranolol 
Verapamil 
12 
0t 
60 
0 
0 
ot 
0 
ot 
0 
70 
0 
30 
0 
0 
ot 
ot 
35 
0 
0 
r30t 
85 
0 
z30t 
0+ 
80 
70 
I50 
75 
20 
29 
- 
- 
40 
- 
20 
- 
0 
100 
20 
50 
0 
80 
- 
- 
75 
65 
20 
- 
- 
25 
- 
- 
- 
- 
- 
160 
65 
16 
14 
- 
14 
- 
25 
23 
25 
5 
24 
20 
~ 
- 
14 
I2 
9 
- 
22 
18 
- 
- 
- 
16 
16 
19 
II 
33 
l7$ 
38 
32 
17 
15 
I6 
40 
21 
27 
25 
32 
32 
22 
20 
25 
28 
26 
29 
21 
20 
30 
38 
30 
23 
30 
I7 
26 
18 
59 
107 
98 
52 
44 
51 
112 
63 
84 
76 
72 
92 
74 
66 
74 
84 
71 
77 
64 
59 
80 
134 
70 
59 
85 
56 
75 
62 
35 
35 
40 
3.5 
48 
47 
38 
47 
45 
45 
48 
38 
52 
38 
52 
52 
35 
43 
32 
42 
42 
40 
37 
41 
48 
42 
40 
34 
48 
*At lime of sudden death or cardiac arrest; testimated from the M-mode echocardiogram (6.9.10); Smaximal wall thickness of 17 mm was not localized to one 
left venlricular segment, but involved two or more segments. CA = cardiac arrest: F = female: LV = left ventricular; LVEDP = left ventricular end-diastolic 
pressure; LVID, = left ventricular end-diastolic cavity dimension; LVOT = left ventricular outflow tract: M = male; NYHA = New York Heart Association; 
SD = sudden death; - = data not available. 
with sudden cardiac death (14%) and showed a similar 
prevalence in the control patients (24%). however, only one 
of the four patients with sudden cardiac death and mild 
hypertrophy was an adult. The other three were preadoles- 
cent children; thus, their left ventricular hypertrophy, al- 
though appearing mild in absolute terms, would have been 
more substantial if corrected for body surface area. 
The findings of the present study indicate that marked 
and di$use left ventricular hypertrophy is associated with an 
increased risk of sudden death in asymptomatic or mildly 
symptomatic patients with hypertrophic cardiomyopathy. 
Conversely, sudden death would appear to he uncommon in 
adult patients with relatively mild and localized hypertrophy 
who have not experienced severe symptoms: indeed, only 
one of the adult patients who died suddenly had this pattern 
of hypertrophy. However, it should also be emphasized that 
mild left ventricular hypertrophy does not always constitute 
a benign morphologic feature in hypertrophic cardiomyopa- 
thy. Some patients with modest degrees of left ventricular 
wall thickening may have severe symptoms of cardiac fail- 
ure; in such patients, the mild hypertrophy is often the 
consequence of diffuse and progressive left ventricular wall 
thinning and is associated with a poor prognosis (13-G). 
Clinical ~rn~l~cati~~. Our findings do not imply that left 
ventricular hypertrophy is an independent determinant of 
sudden death in patients with hypertrophic cardiomyopathy. 
Indeed, both the determinants and the mechanisms of sud- 
den death in this disease have not yet been fully defined. 
They are likely to be complex, involving the interaction of 
multiple factors, and may differ in individual patients. How- 
ever, an association has been previously demonstrated (622) 
between magnitude of left ventricular by~e~ro~ 
occurrence of nonsustained ventricular tachycardia in hy- 
pertrophic cardiomyopathy. Thus, the relation that we iden- 
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tifted in this study between extent of hypertrophy and 
sudden cardiac death suggests, by inference, that complex 
ventricular arrhythmias may constitute the mechanism for 
sudden cardiac death in many patients with particularly 
marked left ventricular hypertrophy. 
The present investigation is based on a retrospective 
analysis of data and thus has the intrinsic limitations of such 
a studjl design. Moreover, left ventricular morphology in the 
study patients who died suddenly was compared with that of 
control patients who were alive at the time of the investigation 
but could subsequently die suddenly. Thus, although our 
findings support he concept that more severe left ventricular 
hypertrophy conveys a greater risk for sudden death, our data 
do not permit definitive conclusions regarding the risk of 
dying suddenly in individual patients with different extent of 
hypertrophy. Therefore, caution should be exercised in uti- 
lizing these observations for prospective assessment of prog- 
nosis in patients with hypertrophic ardiomyopathy. 
Conclusions. Our findings show that particularly marked 
and diffuse left ventricular hypertrophy is common in 
asymptomatic or mildly symptomatic patients with hyper- 
trophic cardiomyopathy who die suddenly. Our results also 
suggest that asymptomatic adult patients with only relatively 
mild and localized hypertrophy are probably at low risk of 
dying suddenly. Although these observations demonstrate a 
relation between the magnitude of left ventricular hypertro- 
phy and the occurrence of sudden death in hypertrophic 
cardiomyopathy, a prospective investigation is necessary to 
define more conclusively the risk of sudden death in individ- 
ual patients with this disease and different magnitudes of left 
ventricular hypertrophy. 
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